So You Want to Be a Biopharmaceutical Analyst?

The top-selling drug of 2023? Pembrolizumab (Keytruda) – a monoclonal antibody used extensively in cancer immunotherapy. Biopharma is big business, the market is growing, and analytical scientists with the right skill set will be increasingly in demand.

The rise of biopharmaceuticals is old news, but that does not mean the opportunity has faded – far from it; biologics are muscling out most small molecule medicines from best-selling drugs lists. And the potential of biopharmaceuticals only seems to grow with our increased understanding of human disease. 

Perhaps you’re at the start of your analytical science journey – keen to explore what opportunities lay ahead – or you might be a researcher tempted by a move into industry. Maybe you’re a seasoned QC analyst who is wondering if the grass really is greener on the other side. It’s also possible you work in an adjacent field – food or environmental analysis – but feel like you’d like to apply your talent to human health in a different way. 

To help you on your way, The Analytical Scientist, Agilent Technologies, several friends at Ireland’s National Institute for Bioprocessing Research and Training (NIBRT), and oligonucleotide specialist Axolabs all join forces to offer you a glimpse inside the wonderful world of biopharmaceuticals. 

Together, we are delighted to present you with our digital guide to this diverse and dynamic field with a very bright future.

---